Targeting tumor vasculature with homing peptides from phage display

Seminars in Cancer Biology

Volumn 10, Issue 6, 2000, Pages 435-442

  Ruoslahti, Erkki ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Angiogenesis; Endothelial cells; Homing; Metastasis; Peptides

Indexed keywords

FIBRONECTIN; GENE PRODUCT; PEPTIDE DERIVATIVE;

ANGIOGENESIS; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PERICYTE; PHAGE DISPLAY; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; SMOOTH MUSCLE FIBER; TUMOR VASCULARIZATION;

EID: 0034470931     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0334     Document Type: Article

References (55)

1. Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors
4. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
5. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
6. Clinical applications of angiogenic growth factors and their inhibitors
7. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
8. Special delivery of drugs by targeting to tissue-specific receptors in the vasculature
9. Organ targeting in vivo using phage display peptide libraries
10. An address system in the vasculature of normal tissues and tumors
11. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display
12. Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display
13. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis
14. Phage libraries displaying cyclic peptides with different ring sizes: Ligand specificities of the RGD-directed integrins
15. Alpha v integrins as receptors for tumor targeting by circulating ligands
16. RGD and other recognition sequences for integrins
17. Definition of two angiogenic pathways by distinct αυ integrins
18. Decreased angiogenesis and arthritic disease in rabbits treated with an alpha v beta 3 antagonist
19. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization
20. Targeted apoptosis of synovial neovasculature in murine collagen-induced arthritis (CIA)
21. Tumor targeting with a selective gelatinase inhibitor
22. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds
23. NG2 proteoglycan-binding peptides target tumor neovasculature
24. Human endothelial cells express integrin receptors on the luminal aspect of their membrane
25. A study of the structure, function and distribution of beta 5 integrins using novel anti-beta 5 monoclonal antibodies
26. Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha1beta1 and alpha2beta1 integrins
27. Elevated matrix metalloprotease and angiostatin levels in integrin alpha1 knockout mice cause reduced tumor vascularization
28. Regulation of angiogenesis in vivo by ligation of integrin alpha(5)beta(1) with the central cell-binding domain of fibronectin
29. The α5β1 integrin supports survival of cells on fibronectin and upregulates Bcl-2 expression
30. Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation
31. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis
32. WAF1/CIP1 expression by vascular cell integrin αυβ3 during angiogenesis
33. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression
34. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality, in mice lacking all alpha v integrins
35. Embryonic mesodermal defects in alpha 5 integrin-deficient mice
36. A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins
37. Aminopeptidase N/CD13 is direcdy linked to signal transduction pathways in monocytes
38. Proteolytic remodeling of extracellular matrix
39. Localization matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alphav beta3
40. Interaction between NG2 proteoglycan and PDGF a receptor on 02A cells is required for optimal response to PDGF
41. Signaling vascular morphogenesis and maintenance
42. Signaling angiogenesis and lymphangiogenesis
43. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
44. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and is receptor Eph-B4
45. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border
46. Defective angiogenesis in mide lacking endoglin
47. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents
48. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
49. Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate
50. Anti-cancer activity of targeted proapoptotic peptides
51. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging
52. Antiangiogenic therapy
53. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage
54. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxcackievirus and adenovirus receptro-independent cell entry mechanism
55. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins